The PE Ratio as of May 2025 (TTM) for Imugene Limited (IUGNF) is -1.90

According to Imugene Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.90. This represents a change of -39.35% compared to the average of -3.13 of the last 4 quarters.

Imugene Limited (IUGNF) Historical PE Ratio (quarterly & annually)

How has IUGNF PE Ratio performed in the past?

The mean historical PE Ratio of Imugene Limited over the last ten years is -19.33. The current -1.90 PE Ratio has changed 883.06% with respect to the historical average. Over the past ten years (40 quarters), IUGNF's PE Ratio was at its highest in in the December 2008 quarter at 10.62. The PE Ratio was at its lowest in in the December 2021 quarter at -36.67.

Imugene Limited (IUGNF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Imugene Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Imugene Limited (IUGNF) Average PE Ratio

How has IUGNF PE Ratio performed in the past?

The current PE Ratio of Imugene Limited (IUGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Imugene Limited (IUGNF) PE Ratio vs. Peers

How is IUGNF’s PE Ratio compared to its peers?

Imugene Limited’s PE Ratio is greater than XOMA Corporation (-112.36), greater than XOMA Corporation (-112.36), less than Lumos Pharma, Inc. (-1.04), less than Fortress Biotech, Inc. (-0.72), greater than Rezolute, Inc. (-3.32), less than Eliem Therapeutics, Inc. (-1.04), greater than Anebulo Pharmaceuticals, Inc. (-3.65), less than Enochian Biosciences, Inc. (-0.85), greater than Connect Biopharma Holdings Limited (-2.69), less than Nuvation Bio Inc. (-1.24), less than Instil Bio, Inc. (-1.25), less than Neoleukin Therapeutics, Inc. (-0.67), greater than Graphite Bio, Inc. (-3.84), less than Salarius Pharmaceuticals, Inc. (-0.22), less than Timber Pharmaceuticals, Inc. (-0.04), less than Artelo Biosciences, Inc. (-0.27), greater than Nutriband Inc. (-5.93), less than Aileron Therapeutics, Inc. (-0.00), less than Creative Medical Technology Holdings, Inc. (-0.65), less than Regen BioPharma, Inc. (-0.84), less than Theralink Technologies, Inc. (-0.02), greater than Enzolytics Inc. (-16.72), less than Sonnet BioTherapeutics Holdings, Inc. (-0.36),

Build a custom stock screener for Imugene Limited (IUGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Imugene Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Imugene Limited (IUGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Imugene Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.